1,311
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Prison-based needle and syringe programmes (PNSP) – Still highly controversial after all these years

&
Pages 103-112 | Received 15 Jun 2015, Accepted 22 Jan 2016, Published online: 23 May 2016

References

  • Allwright, S., Bradley, F., Long, J., Barry, J., Thornton, L., & Parry, JV. (2010). Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors
  • Anex. (2010). With conviction: The case for controlled needle and syringe programs in Australian Prisons. Melbourne, Australia: Anex
  • Arain, A., Robaeys, G., & Stöver, H. (2014). Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infectious Diseases, 14(Suppl 6), S17. DOI: 10.1186/1471-2334-14-S6-S17
  • Boys, A., Farrell, M., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., … Taylor, C. (2002). Drug use and initiation in prison: Results from a national prison survey in England and Wales. Addiction, 97, 1551–1560. DOI: 10.1046/j.1360-0443.2002.00229.x
  • Burrows, D., & Wodak, A. (2005). Harm reduction in Iran; issues in national scale-up. WHO
  • Busch, M., Grabenhofer-Eggerth, A., Weigl, M., & Wirl, C. (2013). Report on the current state of play of the 2003 Council Recommendation on the prevention and reduction of health-related harm, associated with drug dependence, in the EU and candidate countries – Final Report. Gesundheit Österreich
  • Cook, C. (2009). Harm reduction policy and practice worldwide: an overview of national support for harm reduction and policy and practice. London: International Harm Reduction Association
  • Crespo, R., Codern, N., Major, X., Guerrero R., Ayneto, X., Muñoz, Y., & Maresme, M. (2012). What works, for whom in what circumstances? Qualitative evaluation of needle exchange programs in Catalan prisons. Presentation ACCESS conference - Drug users in custody: Learning the lessons. Workshop, 5th October, Milano/Italy
  • Dolan, K., & Wodak, A. (1996). An international review of methadone provision in prisons. Addiction Research, 4, 85–97. DOI: 10.3109/16066359609005565
  • Dolan, K. (2015). Epidemiology of HIV, hepatitis B and hepatitis C, and TB among prisoners. In: Lancet: (HIV in prison paper 1) (in press)
  • ECDC/European Centre for Disease Prevention and Control and EMCDDA/European Monitoring Centre for Drugs and Drug Addiction. (2011). Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC, 2011. Stockholm
  • ECDC. (2013). Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress
  • Elger, B.S., & Shaw, D.M. (2016). Confidentiality in prison health care – A practical guide. In Elger, B., Ritter, C., & Stöver, H. (Eds.), Emerging issues in prison health. Springer
  • EMCDDA. (2012). Prisons and drugs in Europe: the problem and responses, printed in Luxembourg. Retrieved from http://www.emcdda.europa.eu/publications/selected-issues/prison
  • Enggist, S., & Klaue, K. (2010). Bekämpfung von Infektionskrankheiten im Gefängnis (BIG). Bundesamt für Gesundheit. Presentation 19.11.2010 workshop DBDD Berlin/Germany, “Drogen und Haft”
  • Esteban, J.I., Sauleda, S., & Quer, J. (2008). The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology, 48, 148–162. doi:10.1016/j.jhep.2007.07.033
  • European convention for the prevention of torture and inhuman or degrading treatment or punishment. 2002
  • Farhoudi, B., Motevalian, A., Motamedi Heravi, M., Motevali Khameneh, M., Mohraz, M., Rassolinejad, R., … Mohseni, L. (2003). Human immunodeficiency virus and HIV – associated tuberculosis infection and their risk factors in injecting drug users in a prison in Iran. Report to the WHO/EMRO
  • Fazel, S., Bains, P., & Doll, H. (2006). Substance abuse and dependence in prisoners: a systematic review. Addiction, 101, 181–191. doi: 10.1111/j.1360-0443.2006.01316.x
  • Gesundheit Österreich. (2013). Report on the current state of play of the 2003 council recommendation on the prevention and reduction of health-related harm, associated with drug dependence, in the EU and candidate countries. Retrieved from http://www.goeg.at/en/BerichtDetail/project_berichte282.html_en.pdf (accessed on 16 January 2016)
  • Haber, P.S., Parsons, S.J., Harper, S.E., White, P.A., Rawlinson, W.D., & Lloyd, A.R. (1999). Transmission of hepatitis C within Australian prisons. Medical Journal of Australia, 171, 31–33
  • Harm Reduction Coalition. (2007). Syringe Exchange in Prisons: The International Experience
  • Hedrich, D., Alves, P., Farrell, M., Stöver, H., Möller, L., & Mayet, S. (2012). The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction (in press). DOI: 10.1111/j.1360-0443.2011.03676.x. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21955033
  • Hellard, M.E., Hocking, J.S., & Crofts, N. (2004). The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiology and Infection, 132, 409–415
  • Hoffmann, P. (2012). PNSP. Presentation 20 June 2011. Luxembourg
  • Hoover, J., & Jürgens, R. (2009). Harm reduction in prison: The Moldova model. OSI Public Health Program
  • Human Rights Watch. (2006). ‘Rhetoric and risk: human rights abuses impeding Ukraine’s fight against HIV/AIDS’. Retrieved from www.hrw.org/en/reports/2006/03/01/rhetoric-and-risk
  • International HIV/AIDS Alliance. (2010). HIV and drug use: Community responses to injecting drug use and HIV
  • Jürgens, R. (2003). HIV/AIDS prevention for drug dependent persons within the criminal justice system. Presented at the Commission on Narcotic Drug Ministerial Segment. Ancillary Meeting on HIV/AIDS and Drug Abuse. Vienna, 16 April 2003
  • Jürgens, R., Ball, A., & Verster, A. (2009). Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infectious Diseases, 9, 57–66. doi:10.1016/S1473-3099(08)70305-0
  • Keene, J. (1997). Drug misuse in prison: views from inside: a qualitative study of prison staff and inmates. The Howard Journal of Criminal Justice, 36, 28–41. doi: 10.1111/1468-2311.00037
  • Läubli, M., & Weber, M. (2000). Swiss Federal Office of Public Health, Evaluation Services, Prevention and Harm Reduction Measures within the Swiss Prison Context: summary of evaluation and research findings – 1993–1999. Bern
  • Lines, R., Jürgens, R., Stöver, H., Kaliakbarova, G., Laticevschi, D., Nelles, J., … Curtis, M. (2004). Dublin declaration on HIV/AIDS in prisons in Europe and Central Asia. Prison Health is Public Health. Dublin, Ireland
  • Lines, R., Jürgens, R., Betteridge, G., & Stöver, H. (2005). Taking action to reduce injecting drug-related harms in prisons: the evidence of effectiveness of prison needle exchange in six countries. International Journal of Prisoner Health,1, 49–64. http://dx.doi.org/10.1080/17449200500157085
  • Lines, R., Jürgens, R., Betteridge, G., Laticevschi, D., Nelles, J., & Stöver, H. (2006). Prison needle exchange: Lessons from a comprehensive review of international evidence and experience (2nd ed.). Canadian HIV/AIDS Legal Network
  • Majo, X. (2014). Spritzenvergabe in spanischen Gefängnissen. In Stöver, H., & Knorr, B. (Eds.), HIV und Hepatitis-Prävention in Haft – keine Angst vor Spritzen! Oldenburg: BIS-Verlag
  • Majó, X., Folch, C., Casabona, J., Brugal, M.T., Meroño, M., & Gonzalez, V. (2010). Accessibilitat i retorn de xeringues en el consum injectat de drogues a catalunya. Oldenburg: BIS-Verlag
  • Mathers, B., Degenhardt, L., Ali, H., Wiessing, L., Hickman, M., Mattick, R.P., … 2009 Reference Group to the UN on HIV and Injecting Drug Use. (2010). HIV prevention, treatment and care for people who inject drugs: A systematic review of global, regional and national coverage. The Lancet, 375, 1014–1028. doi: 10.1016/S0140-6736(10)60232-2
  • Matic, S., Lazarus, J.V., Nielsen, S., & Laukamm-Josten, U. (Eds.). (2008). Progress on implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. Copenhagen, WHO Regional Office for Europe. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0011/53858/E92606.pdf (assessed on 29 March 2016)
  • Matters of Substance. (2012). Should needle exchange programmes be introduced into prisons? Drugfoundation New Zealand. Retrieved from www.drugfoundation.org.nz
  • Meyenberg, R., Stöver, H., Jacob, J., & Pospeschill, M. (1999). Infektionsprophylaxe im Niedersächsischen Justizvollzug – Abschluβbericht. Bd. 3 der Schriftenreihe “Gesundheitsförderung im Justizvollzug”. Oldenburg: BIS-Verlag, 508 S. Retrieved from http://oops.uni-oldenburg.de/frontdoor.php?source_opus=716
  • Michel, L., Jauffret-Roustide, M., Blanche, J., Maguet, O., Calderon, Chr., Cohen, J., & Carrieri, P.M. (2011). Limited access to HIV prevention in French prisons (ANRS PRI2DE): Implications for public health and drug policy. BMC Public Health, 11, 400. DOI: 10.1186/1471-2458-11-400
  • Ministerio del Interior/Ministerio de Sanidad y Consumo. (2002). Needle exchange in prison. Framwork Program. Madrid
  • Office of the United Nations High Commissioner for Human Rights and the Joint United Nations Programme on HIV/AIDS. (2002). HIV/AIDS and Human Rights International Guidelines. Third International Consultation on HIV/AIDS and Human Rights Geneva, 25–26 July 2002
  • Open Society Institute. (2009). At what cost? HIV and human rights consequences of the global “war on drugs”. Retrieved from www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/atwhatcost_20090302
  • Robaeys, G., Arain, A., Stöver, H. (2016). Hepatitis C viral infection in prisons. In Elger, B., Ritter, C., & Stöver, H. (Eds.), Emerging issues in prison health. SpringerRoca, X.M. (without year). Trying to overcome inequity and discrimination in prison health: The syringe exchange experience in Catalonia and Spain. Presentation
  • Shahbazi, M., Farnia, M., Keramati, M.R., & Alasvand, R. (2010). Advocacy and piloting the first needle and syringe exchange program in Iranian prisons. Retrovirology, 7, P81. doi: 10.1186/1742-4690-7-S1-P81
  • Shewan, D., Stöver, H., & Dolan, K. (2005). Injecting in prisons. In Pates, R., McBride, A., & Arnold, K. (Eds.), Injecting illicit drugs (pp. 69–81). Oxford: Blackwell
  • Spaulding, A.C., Greene, C., Davidson, K., Schneidermann, M., & Rich, J. (1999). Hepatitis C in state correctional facilities. Preventive Medicine, 28, 92–100. doi:10.1006/pmed.1998.0418
  • Stöver, H., & Trautmann, F. (Eds.). (2001). Risk reduction for drug users in prisons. Encouraging Health Promotion for Drug Users within the Criminal Justice System. Utrecht: Trimbos
  • Stöver, H., & Nelles, J. (2003). Ten years of experience with needle and syringe exchange programmes in European Prisons. International Journal of Drug Policy, 14, 437–444. doi:10.1016/j.drugpo.2003.08.001
  • Stöver, H. (2003). 10 years of syringe provision to intravenous drug users in prisons – an end to the projects in Germany. Newsletter
  • Stöver, H., & Lines, R. (2006). Silence still = death. 25 years of HIV/AIDS in prisons. World Health Organisation/WHO – Regional Office for Europe (ed.): 25-Years of HIV/AIDS in Europe, S. 67–85
  • Stöver, H., Weilandt, C., Zurhold, H., Hartwig, C., & Thane, K. (2008). Final report on prevention, treatment, and harm reduction services in prison, on reintegration services on release from prison and methods to monitor/analyse drug use among prisoners. Brussels, European Commission, Directorate-General for health and Consumers, (SANCO/2006/C4/02). Retrieved from http://ec.europa.eu/health/ph_determinants/life_style/drug/documents/drug_frep1.pdf (accessed on 29 March 2016)
  • Stöver, H. (2014). How to improve HIV/TB prevention, treatment and care in prisons. Comment améliorer la prévention, les soins et le traitement du VIH et de la tuberculose en milieu carcéral. In: Aidspan. Independent observer of the global fund. 31 October 2014. Retrieved from http://aidspan.org/gfo_article/how-improve-hivtb-prevention-treatment-and-care-prisons
  • Stöver, H. (2016). Drug services and harm reduction practice in prisons. In Elger, B., Ritter, C., & Stöver, H. (Eds.), Emerging issues in prison health. Springer
  • Torre, R., de la Acín, E., Sanz, J., & Arroyo, J.M. (2009). Le Programme D’ Échange de Seringues en Milieu Pénitentiaire en Espagne. Présentation: Journée nationale Prison. Représentations, pertinence et faisabilité dans le contexte des prisons françaises. Maire du 10ème, Paris, 25 juin 2009. Espagne: Division Santé de la Direction Générale Pénitentiaire – Ministère de l’Intérieur
  • UNAIDS. (2006). Report on the Global AIDS Epidemic, May 2006, p. 114. Retrieved from www.unaids.org/en/HIV_data/2006GlobalReport/default.asp
  • UNAIDS. (2006). Islamic Republic of Iran Country Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS Declaration of Commitment. Office of the Under-secretary for Health, Ministry of Health and Medical Education, Centre for Diseases Management. Retrieved from: http://data.unaids.org/pub/Report/2006/2006_country_progress_report_iran_en.pdf?preview=true
  • UNAIDS. (2015). HIV in prisons and other closed settings. Retrieved from http://www.unaids.org/sites/default/files/media_asset/20151012_UNAIDS_PCB37_15-21_EN.pdf
  • United Nations Commission on Human Rights. (1996). HIV/AIDS in Prisons – Statement by the Joint United Nations Programme on HIV/AIDS (UNAIDS). Presented at the 52nd session; item 8 of the agenda. Geneva
  • United Nations General Assembly. (1990). Basic principles for the treatment of prisoners. 14 December 1990 UNGA Res 45/111, annex, 45 UN GAOR Supp (No 49A)at 200. Retrieved from UN Doc A/45/49http://www.un.org/documents/ga/res/45/a45r111.htm
  • United Nations Office on Drugs and Crime. (2010). HIV in prisons: Situation and needs assessment toolkit. Retrieved from http://www.unodc.org/documents/hiv-aids/publications/HIV_in_prisons_situation_and_needs_assessment_document.pdf
  • UNODC. (2014). World Drug Report 2014. New York (NY): UNODC
  • UNODC. (2015). A handbook for starting and managing needle and syringe programmes in prisons and other closed settings. UNODC. Retrieved from http://www.unodc.org/documents/hiv-aids/publications/Prisons_and_other_closed_settings/ADV_COPY_NSP_PRISON_AUG_2014.pdf
  • UNODC, WHO, UNAIDS. (2006). HIV/AIDS prevention, care, treatment and support in prison settings. A framework for an effective national response. Retrieved from http://www.unodc.org/documents/hiv-aids/HIV-AIDS_prisons_Oct06.pdf
  • UNODC/ILO/UNDP/WHO/UNAIDS. (2013). HIV prevention, treatment and care in correctional settings and other closed settings: A comprehensive package of interventions. Retrieved from https://www.unodc.org/documents/hiv-aids/HIV_prisons_advance_copy_july_2012_leaflet_UNODC_ILO_UNDP_Ebook.pdf
  • UNODC/WHO/UNAIDS. (2006). AIDS prevention, care, treatment and support in prison settings: a framework for an effective national response. Retrieved from http://www.who.int/hiv/pub/idu/framework_prisons.pdf?ua=1
  • Vescio M.F., Longo, B., Babduieri, S., Starnini, G., Carbonara, S., Rezza, G., & Monarca, R. (2008). Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. Journal of Epidemiology and Community Health, 62, 305–313. doi: 10.1136/jech.2006.051599
  • Viitanen, P., Vartiainen, H., Aarnio, J., von Gruenewaldt, V., Hakamäki, S., Lintonen, T., … Joukamaa, M. (2011). Hepatitis A, B, C and HIV infections among Finnish female prisoners–young females a risk group. Journal of Infection, 62, 59–66. doi:10.1016/j.jinf.2010.10.011
  • Vlahov, D., Nelson, K.E., Quinn, T.C., & Kendig, N. (1993). Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. European Journal of Epidemiology, 9, 566–569. DOI: 10.1007/BF00209538
  • WHO, UNODC, UNAIDS. (2007). Interventions to ADDRESS HIV in prisons: Drug dependence treatments. Evidence for Action Technical Papers. Retrieved from www.unodc.org/unodc/en/hiv-aids/publications.html
  • WHO, UNODC, UNAIDS. (2007). Guide to starting and managing needle and syringe programmes. Geneva
  • WHO, UNODC, UNAIDS. (2007). Interventions to address HIV in prisons. Evidence for action technical papers. Geneva, WHO, pp. 59–64. Retrieved from http://www.who.int/hiv/pub/prisons/e4a_prisons/en/index.html
  • WHO, UNODC, UNAIDS. (2007). Effectiveness of interventions to address HIV in prisons. Evidence for action technical papers. Geneva: WHO, 2007b
  • WHO, UNODC, UNAIDS. (2009). Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Retrieved from http://www.who.int/hiv/pub/idu/targetsetting/en/index.html
  • WHO/ILO. (2007). Post-exposure prophylaxis to prevent HIV infection. Joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection. Retrieved from http://www.who.int/hiv/pub/guidelines/PEP/en/
  • WHO/UNAIDS. (ed.; 2008). Progress on implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia progress on implementing the Dublin. Kopenhagen: WHO/UNAIDS, S. 223–231
  • WHO/UNAIDS/UNODC. (2007). Guide to starting and managing needle and syringe programmes. Washington, DC: World Health Organisation, Department of HIV/AIDS
  • WHO/UNODC/UNAIDS. (2007). Interventions to address HIV in prisons: Needle and syringe programmes and decontamination strategies. Evidence for action technical papers. Geneva. Retrieved from http://www.who.int/hiv/pub/idu/prisons_needle/en/index.html
  • WHO/UNODC/UNAIDS. (2007). Interventions to address HIV in prisons: needle and syringe programmes and decontamination strategies/Ralf Jürgens. (Evidence for action technical papers). Geneva
  • Wolff H. (2014). Spritzenvergabe in haft in der Schweiz. In Stöver, H., & Knorr, B. (Eds.). HIV und Hepatitis-Prävention in Haft – keine Angst vor Spritzen! BIS-Verlag Oldenburg
  • World Health Organization Europe. (2005). Status paper of prison, drugs and harm reduction. Copenhagen: World Health Organization Europe
  • World Health Organization. (2004). Advocacy guide: HIV/AIDS prevention among injecting users: workshop manual. World Health Organization, UNAIDS. Retrieved from http://www.who.int/hiv/pub/advocacy/en/advocacyguideen.pdf
  • World Health Organization. (2014). Consolidated guidelines on hiv prevention, diagnosis, treatment and care for key populations. Retrieved from http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1
  • Zimmermann, R. (2014). Hepatitis C und drogenkonsum epidemiologie global und in Deutschland. 6. Fachtag hepatitis C und drogengebrauch Berlin
  • Zurhold, H., Haasen, C., & Stöver, H. (2005). Female drug users in European prisons: a European study of prison policies, prison drug services and the women’s perspectives. Oldenburg, D: Bibliotheks- und Informationssystem der Carl von Ossietzky Universität
  • Zurhold, H., & Stöver, H. (2015). Provision of harm reduction and drug treatment services in custodial settings – Findings from the European ACCESS study. Drugs: Education, Prevention & Policy, DOI: 10.3109/09687637.2015.1112363

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.